Madrigal Pharmaceuticals Statistics
Total Valuation
MDGL has a market cap or net worth of $6.13 billion. The enterprise value is $5.45 billion.
Important Dates
The next estimated earnings date is Wednesday, August 6, 2025, before market open.
Earnings Date | Aug 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
MDGL has 22.20 million shares outstanding. The number of shares has increased by 13.87% in one year.
Current Share Class | 22.20M |
Shares Outstanding | 22.20M |
Shares Change (YoY) | +13.87% |
Shares Change (QoQ) | +0.74% |
Owned by Insiders (%) | 4.95% |
Owned by Institutions (%) | 71.08% |
Float | 12.18M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 19.11 |
Forward PS | 9.08 |
PB Ratio | 8.69 |
P/TBV Ratio | 8.75 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 17.19 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.91, with a Debt / Equity ratio of 0.17.
Current Ratio | 5.91 |
Quick Ratio | 5.41 |
Debt / Equity | 0.17 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -30.09 |
Financial Efficiency
Return on equity (ROE) is -50.16% and return on invested capital (ROIC) is -29.54%.
Return on Equity (ROE) | -50.16% |
Return on Assets (ROA) | -25.56% |
Return on Invested Capital (ROIC) | -29.54% |
Return on Capital Employed (ROCE) | -51.26% |
Revenue Per Employee | $601,104 |
Profits Per Employee | -$741,646 |
Employee Count | 528 |
Asset Turnover | 0.31 |
Inventory Turnover | 0.38 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +17.05% in the last 52 weeks. The beta is -1.08, so MDGL's price volatility has been lower than the market average.
Beta (5Y) | -1.08 |
52-Week Price Change | +17.05% |
50-Day Moving Average | 302.76 |
200-Day Moving Average | 293.83 |
Relative Strength Index (RSI) | 43.62 |
Average Volume (20 Days) | 310,378 |
Short Selling Information
The latest short interest is 4.00 million, so 18.02% of the outstanding shares have been sold short.
Short Interest | 4.00M |
Short Previous Month | 4.10M |
Short % of Shares Out | 18.02% |
Short % of Float | 32.85% |
Short Ratio (days to cover) | 10.84 |
Income Statement
In the last 12 months, MDGL had revenue of $317.38 million and -$391.59 million in losses. Loss per share was -$17.97.
Revenue | 317.38M |
Gross Profit | 306.64M |
Operating Income | -425.15M |
Pretax Income | -510.45M |
Net Income | -391.59M |
EBITDA | -423.84M |
EBIT | -425.15M |
Loss Per Share | -$17.97 |
Full Income Statement Balance Sheet
The company has $843.07 million in cash and $119.77 million in debt, giving a net cash position of $723.30 million or $32.58 per share.
Cash & Cash Equivalents | 843.07M |
Total Debt | 119.77M |
Net Cash | 723.30M |
Net Cash Per Share | $32.58 |
Equity (Book Value) | 710.64M |
Book Value Per Share | 32.03 |
Working Capital | 820.74M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$395.31 million and capital expenditures -$1.11 million, giving a free cash flow of -$396.41 million.
Operating Cash Flow | -395.31M |
Capital Expenditures | -1.11M |
Free Cash Flow | -396.41M |
FCF Per Share | -$17.85 |
Full Cash Flow Statement Margins
Gross margin is 96.61%, with operating and profit margins of -133.95% and -123.38%.
Gross Margin | 96.61% |
Operating Margin | -133.95% |
Pretax Margin | -123.38% |
Profit Margin | -123.38% |
EBITDA Margin | -133.54% |
EBIT Margin | -133.95% |
FCF Margin | n/a |
Dividends & Yields
MDGL does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -13.87% |
Shareholder Yield | -13.87% |
Earnings Yield | -6.34% |
FCF Yield | -6.42% |
Dividend Details Analyst Forecast
The average price target for MDGL is $420.63, which is 52.30% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $420.63 |
Price Target Difference | 52.30% |
Analyst Consensus | Strong Buy |
Analyst Count | 10 |
Revenue Growth Forecast (5Y) | 82.59% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
MDGL has an Altman Z-Score of 9.76.
Altman Z-Score | 9.76 |
Piotroski F-Score | n/a |